Claudio Bordignon,Catia Traversari,Gian Paolo Rizzardi
申请号：
US15060071
公开号：
US20170252435A1
申请日:
2016.03.03
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A pharmaceutical product comprising (a) a conjugation product of TNF and a tumour- or tumour vasculature-targeting peptide comprising an NGR, DGR, isoDGR or RGD motif and (b) a cell comprising a chimeric antigen receptor (CAR), wherein the CAR comprises an antigen-specific targeting domain which targets a tumour antigen.
